Syringe exchange programs --- United States, 2008

Morbidity and Mortality Weekly Report

Volumn 59, Issue 45, 2010, Pages 1488-1491

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ADDICTION; ARTICLE; CLASSIFICATION; COUNSELING; DISEASE TRANSMISSION; ECONOMICS; FINANCIAL MANAGEMENT; HEALTH SERVICE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; INFORMATION PROCESSING; PATIENT REFERRAL; PREVENTIVE HEALTH SERVICE; UNITED STATES;

COUNSELING; DATA COLLECTION; FINANCING, GOVERNMENT; HEALTH SERVICES; HEPATITIS B; HEPATITIS C; HIV INFECTIONS; HUMANS; INFECTION CONTROL; NEEDLE-EXCHANGE PROGRAMS; REFERRAL AND CONSULTATION; SUBSTANCE-RELATED DISORDERS; UNITED STATES;

EID: 78649484872     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. National Institute on Drug Abuse. Principles of HIV prevention in drug-using populations: a research based guide. Bethesda, MD: National Institutes of Health; 2002. NIH publication no. 02-4733. Available at http://www.nida.nih.gov/pohp/faq_1.html. Accessed November 10, 2010.
2. CDC. Syringe exchange programs---United States, 2005. MMWR 2007;56:1164--7.
3. Des Jarlais D, McKnight C, Goldblatt C, Purchase D. Doing harm reduction better: syringe exchange in the United States. Addiction 2009;104:1441--6.
4. Academy for Educational Development. Preventing blood-borne infections among injection drug users: a comprehensive approach. Atlanta, GA: US Department of Health and Human Services, CDC; 2000. Available at http://www.cdc.gov/idu/pubs/ca/comprehensive-approach.pdf. Accessed November 10, 2010.
5. Institute of Medicine. Preventing HIV infection among injecting drug users in high risk countries: an assessment of the evidence. Washington, DC: The National Academies Press; 2006.
6. Palmateer N, Kimber J, Hickman M, Hutchinson S, Rhodes T, Goldberg D. Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews. Addiction 2010;105:844--59.
7. Hall HI, Song R, Rhodes P, et al. HIV Incidence Surveillance Group. Estimation of HIV incidence in the United States. JAMA 2008;300:520--9.
8. CDC. Surveillance for viral hepatitis---United States, 2007. MMWR 2009;58(No. SS-3).
9. Belani HK, Muennig PA. Cost-effectiveness of needle and syringe exchange for the prevention of HIV in New York City. J HIV AIDS Soc Serv 2008;7:229--40.
10. Des Jarlais DC, Perlis T, Arasteh K, et al. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990--2001. AIDS 2005;19(Suppl 3):S20--5.